Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2013.04.001 ◽

2013 ◽

Vol 130 (1) ◽

pp. 12-18 ◽

Cited By ~ 85

Author(s):

Lisa M. Landrum ◽

James Java ◽

Cara A. Mathews ◽

Grainger S. Lanneau ◽

Larry J. Copeland ◽

...

Keyword(s):

Ovarian Cancer ◽

Prognostic Factors ◽

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)79161-9 ◽

2008 ◽

Vol 2008 ◽

pp. 64-65

Author(s):

J.T. Thigpen

Keyword(s):

Ovarian Cancer ◽

Prognostic Factors ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.04.041 ◽

2011 ◽

Vol 122 (3) ◽

pp. 521-526 ◽

Cited By ~ 42

Author(s):

Chad A. Hamilton ◽

Austin Miller ◽

Caela Miller ◽

Thomas C. Krivak ◽

John H. Farley ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

The Impact

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/0090-8258(92)90100-w ◽

1992 ◽

Vol 47 (2) ◽

pp. 159-166 ◽

Cited By ~ 388

Author(s):

William J. Hoskins ◽

Brian N. Bundy ◽

J.Tate Thigpen ◽

George A. Omura

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

Small Volume ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Free Interval

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.02.014 ◽

2006 ◽

Vol 101 (3) ◽

pp. 390-397 ◽

Cited By ~ 26

Author(s):

Angeles Alvarez Secord ◽

Paula S. Lee ◽

Kathleen M. Darcy ◽

Laura J. Havrilesky ◽

Lisa A. Grace ◽

...

Keyword(s):

Ovarian Cancer ◽

Poor Prognosis ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Maspin Expression

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.11.013 ◽

2006 ◽

Vol 100 (1) ◽

pp. 27-32 ◽

Cited By ~ 227

Author(s):

Joan L. Walker ◽

Deborah K. Armstrong ◽

Helen Q. Huang ◽

Jeffrey Fowler ◽

Kenneth Webster ◽

...

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2004.05.033 ◽

2004 ◽

Vol 94 (2) ◽

pp. 368-374 ◽

Cited By ~ 40

Author(s):

David H Moore ◽

James T Kauderer ◽

Jeffrey Bell ◽

John P Curtin ◽

Linda Van Le

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Alternative Treatments ◽

Oncology Group Study ◽

Factors Influencing

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.01.008 ◽

2012 ◽

Vol 125 (2) ◽

pp. 421-426 ◽

Cited By ~ 32

Author(s):

Jennifer M. Rubatt ◽

Kathleen M. Darcy ◽

Chunqiao Tian ◽

Franco Muggia ◽

Rajiv Dhir ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Outcomes ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Oncology Group Study ◽

Pre Treatment ◽

Tumor Expression

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A gynecologic oncology group study

International Journal of Gynecology & Obstetrics ◽

10.1016/0020-7292(91)90782-z ◽

1991 ◽

Vol 36 (2) ◽

pp. 170-170

Author(s):

W.T. Creasman ◽

G.A. Omura ◽

M.F. Brady ◽

E. Yordan ◽

P.J. DiSaia ◽

...

Keyword(s):

Ovarian Cancer ◽

Randomized Trial ◽

Gynecologic Oncology ◽

Stage Iii ◽

Bacillus Calmette Guerin ◽

Oncology Group ◽

Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: Results of a gynecologic oncology group study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/0360-3016(95)00252-9 ◽

1996 ◽

Vol 34 (1) ◽

pp. 139-147 ◽

Cited By ~ 14

Author(s):

Marcus E. Randall ◽

Rolland J. Barrett ◽

Nick M. Spirtos ◽

Eva Chalas ◽

Howard D. Homesley ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Abdominal Radiotherapy